ClinicalTrials.gov
public full text
Public Domain
Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT
Low dose Rabbit Antithymocyte Globulin plus Low-dose post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation for patients with hematologic malignancies
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT#866851
- A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.#844724
- Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation#826558
- Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy#858001
- PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT#1093512
Record · ID 890604
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive